Work

Comprehensive Analysis of Circulating Biomarkers for Early Detection, Risk Stratification, and Personalized Management of Heart Failure Across Diverse Patient Populations

Year: 2025

Type: article

Abstract: Heart failure (HF) is a global health burden with rising prevalence, necessitating innovative diagnostic and management strategies. Circulating biomarkers have emerged as promising tools for early detection, risk stratification, and personalized treatment of HF. This paper provides a comprehensive review of key biomarkers such as natriuretic peptides, troponins, galectin-3, ST2, and novel multi-omic markers. We analyze their clinical significance, predictive value across diverse patient populations, and integration into precision medicine. Furthermore, we explore limitations and the future scope of biomarker-driven HF management.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.14794595

Author: Researcher

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6967808615

FWCI:

Cites:

Cited by:

Related to: